Obesity affects men and women with distinct health risks

New research from Turkey shows that men with obesity tend to develop more abdominal fat and liver stress, while women exhibit higher inflammation and cholesterol levels. These findings, presented at the European Congress on Obesity in Istanbul, highlight sex-based differences that could inform personalized treatments. The study analyzed patients treated between 2024 and 2025.

A team from Dokuz Eylul University in Izmir examined 886 women, average age 45, and 248 men, average age 41, at their Obesity Clinic. Men had a higher body mass index of 37.5 kg/m² compared to 36 kg/m² for women, along with larger waist circumferences at 120 cm versus 108 cm and elevated systolic blood pressure of 128 mmHg against 122 mmHg. They also showed higher levels of liver enzymes ALT and GGT, triglycerides, and creatinine, indicating potential liver and metabolic issues, as well as greater visceral fat around organs linked to heart and metabolic diseases. Women, meanwhile, had elevated total cholesterol at 215 mg/dL versus 203 mg/dL and LDL cholesterol at 130 mg/dL versus 123 mg/dL. Inflammatory markers such as C-reactive protein, erythrocyte sedimentation rate, and platelet count were higher in women, suggesting a stronger immune response influenced by factors like hormones and genetics. Lead author Dr. Zeynep Pekel stated, 'Our findings reveal intriguing differences in the way men and women respond to obesity. They show just how important gender-specific research is.' Pekel added that biological factors, including oestrogen affecting fat storage and immune activity, likely explain these patterns, with men more prone to visceral fat. The cross-sectional study has limitations, including its focus on Turkish adults, and requires validation in larger, diverse groups. Pekel noted, 'It's still early days and these findings need to be confirmed in other patient groups.' The research was presented as abstract 1854 at the European Congress on Obesity in Istanbul from May 12-15.

Awọn iroyin ti o ni ibatan

Realistic illustration of a severely obese patient in ICU highlighting tripled risk of severe infections per new study, with risk comparison chart.
Àwòrán tí AI ṣe

Obesity triples risk of severe infections

Ti AI ṣe iroyin Àwòrán tí AI ṣe

A new study reveals that people with severe obesity face a significantly higher risk of severe or fatal infections. Drawing on data from over 540,000 individuals in the UK and Finland, the risk for grade 3 obesity is three times higher than for those of normal weight. Researchers warn of rising global obesity rates.

New research shows that visceral fat around the waist increases heart failure risk more than BMI, even among those with normal weight. Inflammation mediates much of this link. The findings were presented at the American Heart Association's EPI|Lifestyle Scientific Sessions 2026 in Boston.

Ti AI ṣe iroyin

Experts in India are urging the recognition of abdominal obesity as a new vital sign in Asian Indians to better assess metabolic health risks. An editorial by Amerta Ghosh and Anoop Misra emphasizes the need to measure waist circumference in all patients. This shift addresses the limitations of BMI as a measure of obesity.

A new genetic study indicates that obesity and high blood pressure directly contribute to dementia, beyond merely raising its risk. Researchers from Denmark and the U.K. used advanced methods to establish this causal link, emphasizing prevention through weight and blood pressure management. The findings suggest early interventions could avert vascular-related dementia.

Ti AI ṣe iroyin

Researchers at the University of Oklahoma have discovered that a compound produced by healthy gut bacteria can reduce the risk of fatty liver disease in the offspring of mice fed a high-fat, high-sugar diet during pregnancy and nursing. The compound, indole, derived from breaking down the amino acid tryptophan, improved liver health, blood sugar levels, and weight management in the young mice. This finding highlights the role of the maternal microbiome in preventing metabolic disorders like MASLD in children.

New research published in Nature Medicine reveals that people with prediabetes can normalize blood sugar levels without losing weight. About one in four participants in lifestyle programs achieved this remission, offering protection against diabetes similar to weight loss methods. The key factors involve fat distribution and certain hormones.

Ti AI ṣe iroyin

A new Cochrane review of 22 clinical trials shows that intermittent fasting does not lead to greater weight loss than standard diet advice for overweight or obese adults. The analysis, involving nearly 2,000 participants, challenges the popularity of fasting methods amid rising global obesity rates. Researchers emphasize the need for more long-term studies and personalized approaches.

 

 

 

Ojú-ìwé yìí nlo kuki

A nlo kuki fun itupalẹ lati mu ilọsiwaju wa. Ka ìlànà àṣírí wa fun alaye siwaju sii.
Kọ